INVESTIGACIONES

Investigaciones en Acidemia Metilmalónica (MMA) y Defectos de Cobalamina.

• 

  Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency.

  https://pubmed.ncbi.nlm.nih.gov/23746552/

• 

  Clinical and biochemical outcomes in cobalamin C deficiency with use of high-dose hydroxocobalamin in the early neonatal period.

  https://pubmed.ncbi.nlm.nih.gov/35156754/

• 

  High-dose hydroxocobalamin achieves biochemical correction and improvement of neuropsychiatric deficits in adults with late onset cobalamin C deficiency.

  https://pubmed.ncbi.nlm.nih.gov/32071835/

• 

  Hydroxocobalamin dose escalation improves metabolic control in cblC

  https://pubmed.ncbi.nlm.nih.gov/19821145/

• 

  Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect.

  https://pubmed.ncbi.nlm.nih.gov/23764205/

• 

  Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects: Clinical and biochemical responses.

  https://pubmed.ncbi.nlm.nih.gov/31497484/

• 

  Subcutaneous vitamin B12 administration using a portable infusion pump in cobalamin-related remethylation disorders: a gentle and easy to use alternative to intramuscular injections.

  https://pubmed.ncbi.nlm.nih.gov/33980297/

• 

  Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient.

  https://pubmed.ncbi.nlm.nih.gov/27858373/

• 

  World, early, versus late hidroxocobalamin dose intensification in cblc.

  https://pubmed.ncbi.nlm.nih.gov/37604084/